Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.
Software-hardware symbiosis drives progressLas Vegas, USA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Tanja Rueckert: “Our expertise enables us to bridge the gap between the physical and the digital.”Paul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback